CBIZ Inc

CBZ remains in a Stage 2 uptrend with price well above its 50- and 200-day moving averages, confirming bullish structure. Short-term momentum has eased from overbought, with RSI in neutral territory and flattening EMAs near recent highs. There are no active reversal patterns, suggesting continuation of the medium-term bullish bias. Execution is deferred until a pullback into the rising 9- and 20-day EMA zone or prior support area shows acceptance. We maintain a bullish bias but wait for a tactical entry on a controlled retracement.

• ↑FY26 EPS raised 32% to $2.81 on 8.8% growth forecast.
• ↑Q2 stock rallied 72.2% over 30 days amid AI optimism.
• ↓Q2 revenue $682M (-0.2% YoY), net income $18.6M (-55.6%).